Investment Trusts

Polar Capital Global Healthcare Growth & Income

PCGH:LSE

Polar Capital Global Healthcare Growth & Income

Actions
  • Price (GBX)200.00
  • Today's Change0.00 / 0.00%
  • Shares traded23.66k
  • 1 Year change16.11%
  • Beta0.7362
Data delayed at least 15 minutes, as of Apr 28 2017 16:35 BST.
More ▼

Total returns on £1000

1Y
Fund/benchmarkChange
PricePolar Capital Glb Healthcare (Ordinary Share)+19.75%
NAVPolar Capital Glb Healthcare (Ordinary Share)+19.70%
Morningstar's BenchmarkFTSE World+29.97%

Key statistics

On Friday, Polar Capital Global Healthcare Growth & Income (PCGH:LSE) closed at 200.00, -6.87% below its 52-week high of 214.75, set on Mar 16, 2017.
52-week range
Today
154.00Jun 24 2016214.75Mar 16 2017
Markit short selling activity
Low
Med
High
Shares outstanding120.48m
Market cap241.00m GBP
Total assets248.10m GBP
Total expense ratio1.02%
High200.00
Low200.00
Previous close200.00
Average volume63.30k
YTD Change+2.70%
Beta0.7362%
Diluted NAV (est)207.32
Diluted NAV (last pub)207.78
Premium/Discount-3.53%
Gearing+100.00%
Annual div (ADY)4.15 GBX
Annual div yield (ADY)2.08%
Div ex-dateFeb 09 2017
Div pay-dateFeb 28 2017
Data delayed at least 15 minutes, as of Apr 28 2017 16:35 BST.
More ▼

Board of Directors

1/4

James Robinson, Chairman

2/4

John Aston OBE, Director

3/4

Anthony Brampton, Director

4/4

Antony Milford, Director

Investor Relations Contact

Registered Office
16 Palace Street
London
SW1E 5JD

Switchboard: +44 (0) 20 7227 2700
Fax: +44 (0) 20 7227 2799
investor-relations@polarcapital.co.uk

Company website

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.